Malta tops EU average annual growth in Pharmaceutical Exports, ranks second in Trade balance per capita 16 November 2017 Pharmaceutical Manufacturers Business Section satisfied with Malta’s favourable export performance
Crane Currency Malta plant to be operational by mid-2018 14 December 2016 Global leader in currency printing has decided to open shop in Malta, turning this specialised strand of manufacturing into a new sub-niche in Malta’s economy.
Actavis bought by Israeli pharmaceutical company 31 July 2015 Teva Pharmaceuticals to acquire Allergan Generics for $40 billion. Actavis’ parent company Allergan plc, signed agreement with Teva which will be finalised in 2016.
De Marco says manufacturing’s weak performance requires attention 09 March 2015 Central Bank’s Economic Update confirms Opposition’s legitimate concerns on certain sectors of the economy – shadow finance minister
Industrial producer prices remain ‘stable’ in Malta 03 February 2015 Industrial producer prices down by 1% in both euro area and EU28 • Prices in Malta remain stable
Health manufacturing: a key pillar of Malta’s industry 25 November 2014 Malta’s accession to the European Union in 2004 and the eurozone in 2008 without doubt made the country more attractive for the manufacturing sector primarily due to the single market’s fundamental pillars of free movement of goods, services, capital and people.
Government opens call for construction of fish processing plant 13 October 2014 The government launched a call for the expression of interest for the construction and operation of a fish processing plant at the new Marsa fish market.
Medichem opens Malta HPAPI plant 01 July 2014 Medichem has opened an API plant in Malta touting the country's "unique patent situation" as an attractive option for generic drugmakers.
